Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Ordinary shares, nominal value $0.01 per share
-
Shares outstanding
-
3,394,124
-
Total 13F shares
-
56,853
-
Share change
-
+56,853
-
Total reported value
-
$186,595
-
Price per share
-
$3.29
-
Number of holders
-
29
-
Value change
-
+$186,595
-
Number of buys
-
29
Institutional Holders of EKSO BIONICS HOLDINGS, INC. - Ordinary shares, nominal value $0.01 per share (EKSO) as of Q2 2025
As of 30 Jun 2025,
EKSO BIONICS HOLDINGS, INC. - Ordinary shares, nominal value $0.01 per share (EKSO) was held by
29 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
56,853 shares.
The largest 10 holders included
Cresset Asset Management, LLC, GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, BlackRock, Inc., FNY Investment Advisers, LLC, Compagnie Lombard Odier SCmA, Tower Research Capital LLC (TRC), Golden State Wealth Management, LLC, Roble, Belko & Company, Inc, and IFP Advisors, Inc.
This page lists
29
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.